A 'Fillip' For UK Biotech
Roche Buying Privately Held Piramed for $160M Up Front
By Jennifer Boggs
Wednesday, April 16, 2008
Less than five years after its founding, privately held Piramed Ltd. agreed to be acquired by Roche Holdings Ltd. for $160 million up front in one of the few recent deals to stand out in the slumping UK biotech sector. (BioWorld Today)
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.